JP2025183238A5 - - Google Patents
Info
- Publication number
- JP2025183238A5 JP2025183238A5 JP2025139442A JP2025139442A JP2025183238A5 JP 2025183238 A5 JP2025183238 A5 JP 2025183238A5 JP 2025139442 A JP2025139442 A JP 2025139442A JP 2025139442 A JP2025139442 A JP 2025139442A JP 2025183238 A5 JP2025183238 A5 JP 2025183238A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- subject
- substituted
- pharmaceutical composition
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962939263P | 2019-11-22 | 2019-11-22 | |
| US62/939,263 | 2019-11-22 | ||
| PCT/US2020/061659 WO2021102361A1 (en) | 2019-11-22 | 2020-11-20 | Caspase 6 inhibitors and uses thereof |
| JP2022529561A JP7734663B2 (ja) | 2019-11-22 | 2020-11-20 | カスパーゼ６阻害剤およびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529561A Division JP7734663B2 (ja) | 2019-11-22 | 2020-11-20 | カスパーゼ６阻害剤およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025183238A JP2025183238A (ja) | 2025-12-16 |
| JP2025183238A5 true JP2025183238A5 (https=) | 2026-03-06 |
Family
ID=75981720
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529561A Active JP7734663B2 (ja) | 2019-11-22 | 2020-11-20 | カスパーゼ６阻害剤およびその使用 |
| JP2025139442A Pending JP2025183238A (ja) | 2019-11-22 | 2025-08-25 | カスパーゼ６阻害剤およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529561A Active JP7734663B2 (ja) | 2019-11-22 | 2020-11-20 | カスパーゼ６阻害剤およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250263366A2 (https=) |
| EP (1) | EP4061341A4 (https=) |
| JP (2) | JP7734663B2 (https=) |
| KR (1) | KR20220159346A (https=) |
| CN (1) | CN115335039A (https=) |
| AU (1) | AU2020386639A1 (https=) |
| BR (1) | BR112022009881A2 (https=) |
| CA (1) | CA3162470A1 (https=) |
| IL (1) | IL293222A (https=) |
| MX (1) | MX2022006052A (https=) |
| WO (1) | WO2021102361A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022328634A1 (en) | 2021-08-18 | 2024-02-22 | Chemocentryx, Inc. | Aryl sulfonyl compounds as ccr6 inhibitors |
| WO2023023532A2 (en) | 2021-08-18 | 2023-02-23 | Chemocentryx, Inc. | Aryl sulfonyl (hydroxy) piperidines as ccr6 inhibitors |
| KR20250030560A (ko) * | 2023-08-25 | 2025-03-05 | 재단법인 아산사회복지재단 | Htra 활성제를 유효성분으로 포함하는 퇴행성 질환의 예방 또는 치료용 약학적 조성물 및 htra 활성 조절제의 스크리닝 방법 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6620839B2 (en) | 2000-07-13 | 2003-09-16 | Abbott Laboratories | 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| PT2322525E (pt) | 2006-04-21 | 2013-12-26 | Novartis Ag | Derivados de purina para utilização como agonistas do recetor de adenosina a2a |
| WO2009089011A2 (en) * | 2008-01-08 | 2009-07-16 | Sirtris Pharmaceuticals, Inc. | Resveratrol formulations |
| WO2009148923A1 (en) | 2008-05-29 | 2009-12-10 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
| US8889716B2 (en) * | 2011-05-10 | 2014-11-18 | Chdi Foundation, Inc. | Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof |
| WO2014060392A1 (en) * | 2012-10-16 | 2014-04-24 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Caspase-6 inhibitors for treating t cell activation and/or proliferation disorders |
| CA2904393A1 (en) * | 2013-03-15 | 2014-09-25 | Araxes Pharma Llc | Covalent inhibitors of kras g12c |
| EP3092225B1 (en) | 2014-01-09 | 2019-02-27 | Merck Patent GmbH | Pyrimidine pyrazolyl derivatives and their use as irak inhibitors |
| WO2016020732A1 (en) * | 2014-08-05 | 2016-02-11 | The University Of British Columbia | Modulators of caspase-6 |
| CN104860891B (zh) * | 2014-02-25 | 2017-06-30 | 上海海雁医药科技有限公司 | 芳氨基嘧啶类化合物及其应用以及由其制备的药物组合物和药用组合物 |
| KR20160002318A (ko) * | 2014-06-30 | 2016-01-07 | 한미약품 주식회사 | 피리미딘 유도체 화합물 및 이의 용도 |
| PE20190710A1 (es) | 2014-10-24 | 2019-05-17 | Bristol Myers Squibb Co | Compuestos de indol carboxamida utiles como inhibidores de cinasas |
| ES2899196T3 (es) | 2015-03-09 | 2022-03-10 | Aurigene Discovery Tech Ltd | Derivados de pirazolo[1,5-a][1,3,5]triazina y de pirazolo[1,5-a]pirimidina como inhibidores de CDK |
| WO2017070256A2 (en) | 2015-10-19 | 2017-04-27 | Araxes Pharma Llc | Method for screening inhibitors of ras |
| WO2018022897A1 (en) * | 2016-07-27 | 2018-02-01 | Padlock Therapeutics, Inc. | Covalent inhibitors of pad4 |
| WO2018035061A1 (en) * | 2016-08-15 | 2018-02-22 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| AU2017363313B2 (en) | 2016-11-22 | 2021-06-24 | Dana-Farber Cancer Institute, Inc. | Inhibitors of interleukin-1 receptor-associated kinases and uses thereof |
| KR20190043437A (ko) | 2017-10-18 | 2019-04-26 | 씨제이헬스케어 주식회사 | 단백질 키나제 억제제로서의 헤테로고리 화합물 |
| IL301691A (en) * | 2020-09-30 | 2023-05-01 | Univ Leuven Kath | 1,2,3,4-tetrahydroquinoline derivatives as inhibitors of the yap/taz-tead activation for treating cancer |
-
2020
- 2020-11-20 BR BR112022009881A patent/BR112022009881A2/pt not_active Application Discontinuation
- 2020-11-20 EP EP20888781.0A patent/EP4061341A4/en active Pending
- 2020-11-20 MX MX2022006052A patent/MX2022006052A/es unknown
- 2020-11-20 KR KR1020227021234A patent/KR20220159346A/ko active Pending
- 2020-11-20 AU AU2020386639A patent/AU2020386639A1/en active Pending
- 2020-11-20 CA CA3162470A patent/CA3162470A1/en active Pending
- 2020-11-20 IL IL293222A patent/IL293222A/en unknown
- 2020-11-20 CN CN202080092870.XA patent/CN115335039A/zh active Pending
- 2020-11-20 WO PCT/US2020/061659 patent/WO2021102361A1/en not_active Ceased
- 2020-11-20 US US17/777,832 patent/US20250263366A2/en active Pending
- 2020-11-20 JP JP2022529561A patent/JP7734663B2/ja active Active
-
2025
- 2025-08-25 JP JP2025139442A patent/JP2025183238A/ja active Pending